How Human-Led AI Improves Healthcare Marketing Intelligence
A new white paper from LiveWorld highlights how AI tools for healthcare marketers fall short and what’s needed for more effective marketing strategies.
presented by
presented by
Biotech Showcase™: Where Innovation Meets Investment and Partnerships
Make Biotech Showcase your homebase during the busiest week in healthcare. The event convenes 3,200 life science leaders, including 1,200+ investors and over 340 presenting companies, for three days of breakthrough innovation, investment opportunities and strategic collaborations.
Where Will AI Deployment Benefit Payers the Most?
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.
As Healthcare and Biopharma Companies Embrace AI, Insurance Underwriters See Risks and Opportunities
In an interview, Munich Re Specialty Senior Vice President Jim Craig talked about the risk that accompanies innovation and the important role that insurers play.
Do You Value MedCity News? Take Our Survey!
Take part in our Reader Survey and help us continue to grow!
Get a Snapshot of the Early Stage Life Science Startup Landscape
A webinar scheduled for Thursday May 8 at 1 pm ET sponsored by Mercury will explore how early-stage medtech and biopharma investors are looking at the market and how they're advising startups in the wake of cuts to NIH and SBIR grants.
Webinar: How Fintech Can Accelerate Growth for Early-Stage Life Science Companies
Sign up today and and join us on May 8th where we'll explore how a banking platform approach could be a resource for the needs of entrepreneurs across biotech, diagnostics, and other life science companies.
presented by
Automation Didn’t Dehumanize Care. Bad Systems Did.
We have the opportunity to design systems that give people greater capacity for the work where human presence matters most: listening, understanding, reassuring, deciding, and caring.
How Can Fintech Make it Easier for Early Stage Life Science Companies to Grow?
A webinar on May 8th will explore how a banking platform approach could be a resource for the needs of entrepreneurs across biotech, diagnostics, and other life science companies.
Health Economics and Outcomes Research: Biopharma’s Underappreciated Value Creator
The way ahead for HEOR in biopharma should be built on increasing C-suite visibility and understanding of the value contribution that HEOR makes and demonstrating that a failure to invest in HEOR puts companies at a competitive disadvantage, especially in the face of rising regulatory and payer expectations for evidence.
Vitality in the Supply Chain: The Limitless Potential of ATMPs
The “holy grail” of ATMP-based treatments is to provide cures for some of the world’s most debilitating disease states, but for this to occur, a unified front is needed to democratize these therapies – collaboration from industry, academia, supply chain and, indeed, clinicians and hospitals is paramount to ensuring safe manufacturing and transit.
4 Ways Biopharma Is Applying AI/ML to Improve Drug Development Outcomes
Biopharma companies are harnessing AI tools for multiple aspects of drug development such as identifying drug development targets, modeling a drug's effect on the body, and more.
presented by
From Blind Spots to Better Outcomes: How SNF Data Transparency Strengthens LTSS
What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes.
Why Effective and Efficient Clinical Trial Operations Are More Complex and More Important than Ever in a Post-Pandemic World
Anita Nelsen, Senior Vice President of Clinical Trial Operations at Allucent, shares her insights on how to navigate the drug development landscape.
Apply to MedCity INVEST Pitch Perfect Where Investment Trends and Innovation Converge
In the runup to INVEST and the startup pitch contest, we highlight trends in investment and innovation across bipharma, diagnostics, medical devices, health tech: payer/provider, and health tech: consumer/employer. The deadline has been extended until February 28 and finalists will be announced March 31. Apply today!
Time Is Running Out to Apply for MedCity’s Largest Pitch Contest of the Year
With five tracks of startups across healthcare and life sciences, INVEST Pitch Perfect, scheduled for May 22-24 at the Ritz Carlton in Chicago, is MedCity's largest startup pitch contest of the year.
A VC’s take on the $1.3 billion acquisition of CinCor Pharma by AstraZeneca
Maina Bhaman, a board member of CinCor Pharma reflects on the news from Monday that AstraZeneca is acquiring the Massachusetts startup to bring another option for patients with resistant hypertension.
How L&D in Regulated Industries Can Move Beyond Just Compliance to Impact
The Covid-19 pandemic has forced life sciences companies to take a fresh look at how they do business. But as they reinvent their operations, companies often overlook a critical function: Their learning and development programs.